Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Whole-body muscle electrical stimulation with amino acid support to protect muscle in ICU patients

Official title: The Effect of a Single Session of Whole-body Neuromuscular Electrical Stimulation (NMES), With or Without Subsequent Intake of an Amino Acid Bolus, on Whole-body Protein Turnover in Sedated Intensive Care Unit (ICU) Patients

Run by Wageningen University · NCT07430969 · Data updated 2026-11-12

This trial tests whether whole-body electrical muscle stimulation, with or without a 20 g amino acid bolus, helps maintain or build muscle protein in adults on mechanical ventilation in the ICU.

More Muscle Wasting in Critically Ill trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorWageningen University
Academic / other
Locations1 site (Ede)
StatusRecruiting
StartedJuly 18, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJuly 2, 2026
Trial IDNCT07430969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) in the ICU expected to need mechanical ventilation for at least 48 hours, sedated to RASS −4/−5, receiving gastric tube feeding, and with arterial and venous lines in place are ideal candidates.

Probably not a fit

Patients with contraindications to NMES (open wounds, spinal cord injury, burns, implanted pacemaker/ICD), those with advanced AKI or on continuous hemofiltration, pregnant patients, or those judged unsuitable by the intensivist are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Mechanically ventilated ICU patients are randomized to receive sham stimulation with standard enteral nutrition, active whole-body neuromuscular electrical stimulation (NMES) with standard nutrition, or active NMES followed by a 20 g amino acid bolus. Participants receive continuous infusions of labeled amino acids to measure whole-body protein synthesis, breakdown, and net balance, along with blood sampling and upper-arm ultrasound to assess muscle blood flow. The primary outcome is whole-body protein net balance, with secondary outcomes including protein synthesis, breakdown, oxidation, and muscle glucose uptake. Interventions occur at the bedside while patients remain sedated and receiving enteral feeding.

Why it matters

Potential benefit: If successful, this approach could help preserve or increase muscle protein and reduce muscle wasting in ventilated ICU patients.

How similar studies have gone: Small prior studies suggest NMES can reduce muscle loss in some ICU patients but results are mixed and combining NMES with an amino acid bolus is relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged ≥18 years
* Expected to need mechanical ventilation for at least 48 hours, judged by physician
* Expected to reach a Richmond Agitation-Sedation Scale (RASS) score of -4 or -5 (complete sedation), judged by physician
* Informed consent obtained from the next-of-kin
* Able to or are receiving gastric tube feeding
* Have an arterial and a venous line in situ

Exclusion Criteria:

* Spinal cord injury
* Previous surgery/local wounds that prohibit whole-body NMES
* Conditions that prohibit NMES (such open wounds)
* Chronic neuromuscular disorders (such as Amyotrophic lateral sclerosis (ALS))
* Acute Kidney Injury (AKI) II and III
* Undergoing continuous veno-venous hemofiltration (CVVH)
* Rhabdomyolysis
* Neuromuscular blocking agents
* In the caloric restriction period of refeeding syndrome
* In prone position
* Burn wounds
* ICD/pacemaker
* Pregnant
* Deemed not suitable to participate based upon the judgement of the treating intensivist

Where it's running

  • Hospital Gelderse Vallei
    Ede, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.